Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fujifilm Toyama Chemical Co. Ltd.

Division of Fujifilm Holdings Corp.
fftc.fujifilm.co.jp/en

Latest From Fujifilm Toyama Chemical Co. Ltd.

India COVID-19 Update: Antivirals, Eyes On HCQ-Azithromycin Data

Development work for antivirals such as favipiravir and remdesivir seen as potential treatments for coronavirus is underway in India, with the former’s off-patent status making it more attractive. All eyes are also on data from a French study which highlights the potential of hydroxychloroquine and azithromycin as a COVID-19 treatment.

Research & Development Coronavirus COVID-19

Some Caution Over 'People’s Hope' Remdesivir As China Trials Progress

Although Gilead’s remdesivir shows promise against the coronavirus, efficacy is not guaranteed, one antiviral company executive tells Scrip, as multiple other potential therapies and vaccines move forward.

Coronavirus COVID-19 Clinical Trials

AnGes Takes DNA Vaccine Tack As It Enters Virus R&D Fray

Japanese bioventure goes down the DNA vaccine route, along with several others worldwide, pointing to potential development speed and safety advantages.

Japan Coronavirus COVID-19

Asia Deal Watch: Fujifilm Affiliate Out-Licenses Antifungal Candidate To Canada’s Appili

Novel antifungal T-2307, discovered by FUJIFILM Toyama, works by selectively disrupting mitochondrial function. Excelra and Maruho team up to repurpose existing drugs.

Asia Pacific Deals
See All

Company Information

  • Industry
  • In Vitro Diagnostics
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
      • Molecular Imaging
  • Pharmaceuticals
    • Radiopharmaceuticals, Contrast Agents
  • Therapeutic Areas
  • Cancer
  • Metabolic Disorders
  • Neurology, Nervous System
  • Alias(es)
  • Toyama Chemical Co. Ltd.
  • Fujifilm RI Pharma Co. Ltd.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Japan
  • Parent & Subsidiaries
  • Fujifilm Holdings Corp.
  • Senior Management
  • Junji Okada, Pres.
  • Contact Info
  • Fujifilm Toyama Chemical Co. Ltd.
    Phone: (81) 3 5381 3889
    14-1, Kyobashi 2-Chome
    Chuo-ku
    Tokyo ,
    Japan
UsernamePublicRestriction

Register